Biography
Dr. Paulk is a pioneer in the development of next-generation AAV platforms for gene repair, gene transfer and gene editing for numerous rare diseases and cancer, directed evolution to evolve novel viral capsids, and comparative multiomic approaches to interrogate translational AAV biology. Dr. Paulk is a global KOL in gene therapy and consults extensively for big pharma, and sits on the SABs for Sarepta, Astellas, Dyno, CEVEC, Excision Bio, Whitelab Genomics, and the John's Hopkins Gene Therapy Initiative. She is regularly quoted in STAT, Endpoints, Phacilitate, GEN, Biopharma Dive, Wall Street Journal, and is a frequent guest on Biotech Clubhouse. Dr. Paulk sits on the Scientific Editorial Boards of the journals Nature Gene Therapy and Human Gene Therapy, and is extensively involved in numerous committees within the American Society of Gene & Cell Therapy.